Early recognition of Alzheimer's disease: What is consensual? What is controversial? What is practical?

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL. 13, 1998, Pages 6-18

  Doraiswamy, P Murali ^a   Steffens, David C ^a   Pitchumoni, Suresh ^a   Tabrizi, Sara ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BIOLOGICAL MARKER;

ALGORITHM; ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; HUMAN; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCREENING;

AGED; ALZHEIMER DISEASE; BRAIN; COGNITION DISORDERS; DECISION TREES; DELIRIUM; DEMENTIA, VASCULAR; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; INCIDENCE; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MEMORY DISORDERS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031719865     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Geldmacher DS, Whitehouse PJ. Evaluation of dementia. N Engl J Med 1996;335:330-336
2. Small GW, Rabins PV, Barry PP, et al. Diagnosis and treatment of Alzheimer disease and related disorders: consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 1997;278:1363-1371
3. Ross GW, Abbott RD, Petrovich H, et al. Frequency and characteristics of silent dementia among elderly Japanese-American men. JAMA 1997;277: 800-805
4. Callahan CM, Hendrie HC, Tierney WM. Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Intern Med 1995;122:422-429
5. Dubler NN. The legal and ethical dilemma. In: Kalicki AC, ed. Confronting Alzheimer's Disease. Owing Mills, Md: Rynd Communications;1987: 11-20
6. McCormick WC, Kukull WA, van Belle G, et al. Symptom patterns and comorbidity in the early stages of Alzheimer's disease. J Am Geriatr Soc 1994;42:517-521
7. Larson EB, Reifler BV, Sumi M, et al. Diagnostic tests in the evaluation of dementia: a prospective study of 200 elderly outpatients. Arch Intern Med 1986;146:1917-1922
8. Cooper PJ, Tallman K, Tuokko H, et al. Vehicle crash involvement and cognitive deficit in older drivers. J Safety Res 1993;24:9-17
9. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias of Late Life. Am J Psychiatry 1997;154(suppl 5):1-39
10. Ernst RL, Hay JW, Fenn C, et al. Cognitive function and the costs of Alzheimer disease. Arch Neurol 1997;54:687-693
11. Ernst RL, Hay JW. The US economic and social costs of Alzheimer's disease revisited. Am J Public Health 1994;84:1261-1264
12. Brumback RA, Leech RW. Alzheimer's disease: pathophysiology and the hope for therapy. J Okla State Med Assoc 1994;87:103-111
13. Leon J, Neuman P, Hermann RC, et al. A cross-sectional study on the health related quality of life and health service utilization for mild, moderate, and severely impaired Alzheimer's disease patients [abstract]. Neurology 1998; 50(4);54:A302
14. Cummings J, Benson F, LoVerme S Jr, et al. Reversible dementia. JAMA 1980;243:2434-2439
15. Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: the Confusion Assessment Method: a new method for detection of delirium. Ann Intern Med 1990;113:941-948
16. Levy ML, Cummings JL. Diagnosis of Alzheimer's disease in primary care. Primary Psychiatry 1996;3:30-40
17. Pfeffer RI, Kurosaki TT, Harrah CH, et al. Measurement of functional activities of older adults in the community. J Gerontol 1982;37:323-329
18. American Academy of Neurology. Practice parameter for diagnosis and evaluation of dementia. Neurology 1994;44:2203-2206
19. Katzman R. Should a major imaging procedure (CT or MRI) be required in the workup of dementia? affirmative view. J Fam Pract 1990;31:401-410
20. Clarfield AM, Larson EB. Should a major imaging procedure (CT or MRI) be required in the workup of dementia? opposing view. J Fam Pract 1990; 31:405-410
21. Hoffman J. PET studies in dementia. In: Krishnan KR, Doraiswamy PM, eds. Brain Imaging in Clinical Psychiatry. New York, NY: Marcel Dekker; 1997:533-574
22. Kumar A. PET studies in affective disorders. In: Krishnan KR, Doraiswamy PM, eds. Brain Imaging in Clinical Psychiatry. New York, NY: Marcel Dekker; 1997:215-236
23. Amar K, Wilcock GK, Scott M. The diagnosis of vascular dementia in the light of the new criteria. Age Ageing 1996;25:51-55
24. Hachinski VC, Iliff LD, Zilkha E. Cerebral blood flow in dementia. Arch Neurol 1975; 32:632-637
25. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944
26. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
27. Shergill S, Mullan E, Dath P, et al. What is the clinical prevalence of Lewy body dementia? Int J Geriatr Psychiatry 1994;9:907-912
28. McKeith IG, Galasko D, Kosaka K. et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47:1113-1124
29. Brun A, Englund B, Gustafson L, et al. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994;57: 416-418
30. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease. Statement on use of apolipoprotein E testing for Alzheimer disease. JAMA 1995;274: 1627-1629
31. National Institute on Aging/Alzheimer's Association Working Group. Apolipoprotein E genotyping in Alzheimer's disease. Lancet 1996;347: 1091-1095
32. Roses AD. A model for susceptibility polymorphisms for complex diseases: apolipoprotein E and Alzheimer disease. Neurogenetics 1997;1: 3-11
33. Steffens D. MRI/MRS studies in dementia. In: Krishnan KR, Doraiswamy PM, eds. Brain Imaging in Clinical Psychiatry. New York, NY: Marcel Dekker; 1997:503-532
34. Charles HC, Snyderman T, Ahearn E. Magnetic resonance spectroscopy. In: Krishnan KR, Doraiswamy PM, eds. Brain Imaging in Clinical Psychiatry. New York, NY: Marcel Dekker; 1997:17